Overview
Kevin P. Weinfurt, PhD, is Professor and Vice Chair of Faculty in the Department of Population Health Sciences at Duke University Medical Center and a faculty member of the Duke Clinical Research Institute. He holds secondary appointment as a Professor of Psychology and Neuroscience, Professor of Psychiatry and Behavioral Sciences, Professor of Biostatistics and Bioinformatics, and a Faculty Associate of the Trent Center for Bioethics, Humanities & History of Medicine. Dr. Weinfurt also co-directs the Center for Health Measurement at Duke and is co-director of the Clinical Research Training Program (Masters degree offered through the School of Medicine). Dr. Weinfurt worked as a Special Governmental Employee for the U.S. Food and Drug Administration for four years, helping to create the Patient-Focused Drug Development guidance series. He is also a member of the Secretary's Advisory Committee for Human Research Protections.
Dr. Weinfurt conducts research on measuring patient-reported outcomes, medical decision making, and bioethics. In addition to conducting research, Dr. Weinfurt has taught undergraduate courses in introductory psychology, judgment and decision making, and the psychology of medical decision making; and graduate courses in multivariate statistics, patient-reported outcomes, and research ethics.
Areas of Expertise: Bioethics, Health Measurement, Health Services Research, and Health Behavior
Current Appointments & Affiliations
Recent Publications
Interpreting the meaningfulness of treatment effects estimated in parallel groups designs: comment on Trigg et al.
Journal Article Qual Life Res · July 2025 Draft guidance from the U.S. Food and Drug Administration states that one can interpret a treatment effect on a clinical outcome assessment-based endpoint when expressed as some difference between group means. Recently, Trigg et al. examined different appr ... Full text Link to item CiteThe Argument-Based Approach to Validity Applied to Clinical Outcome Assessments: Some History and Notable Features.
Journal Article Value Health · April 11, 2025 Developing and evaluating clinical outcome assessments (COAs) requires a framework for understanding validity. The validity framework reflected in the most recent draft guidance from the US Food and Drug Administration is the argument-based approach. In th ... Full text Link to item CiteImpact of Disclosing to Patients the Use of Antiretroviral Resistance Testing Results for Molecular HIV Surveillance: A Randomized Experiment in 2 National Surveys.
Journal Article JMIR Public Health Surveill · April 11, 2025 BACKGROUND: Molecular HIV surveillance (MHS) can be used to help identify and respond to emerging clusters of rapidly spreading HIV transmissions, a practice known as cluster detection and response (CDR). In the United States, MHS relies on HIV gene sequen ... Full text Link to item CiteRecent Grants
Nurse LEADS: Training in Nurse-LEd models of care ADdressing the Social Determinants of Health
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2024 - 2029UrogynCREST Program
ResearchCourse Faculty · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2019 - 2029Duke KURe Program
Inst. Training Prgm or CMEMentor · Awarded by National Institute of Diabetes and Digestive and Kidney Diseases · 2013 - 2028View All Grants